William J. Polvino

Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women¹

Henry G. Bone, Robert W. Downs, Joseph Tucci et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 188 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure¹

Johan Svensson, Lars Lönn, John‐Olov Jansson et al. · The Journal of Clinical Endocrinology & Metabolism · 1998 · 161 citations · Full text

Agriculture, Endocrinology, Pharmacotherapy +16

Effect on Body Weight and Safety of RC-1291, a Novel, Orally Available Ghrelin Mimetic and Growth Hormone Secretagogue: Results of a Phase I, Randomized, Placebo-Controlled, Multiple-Dose Study in Healthy Volunteers

José M. Garcia, William J. Polvino · The Oncologist · 2007 · 128 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers

José M. Garcia, William J. Polvino · Growth Hormone & IGF Research · 2009 · 89 citations

Medicine, Endocrinology, Pharmacology +15

Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults¹

Ian Chapman, Ora Hirsch Pescovitz, Gail Murphy et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 63 citations · Full text

Medicine, Endocrinology, Nutrition +17